Corvidia Therapeutics, Inc.
Overview
Corvidia Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of cardiovascular and chronic kidney diseases. As a subsidiary of Novo Nordisk, it leverages cutting-edge technology to target inflammation and oxidative stress pathways.
Therapeutic areas
CardiovascularChronic Kidney Disease
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Corvidia Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.